Wolfspeed emerges from bankruptcy with a restructured balance sheet, slashing debt by 70% and extending maturities to 2030. WOLF's new manufacturing capacity and reduced capex position it for growth, but diluted share count complexities and incentive plans add uncertainty to valuation. The stock trades at just 2x sales, with long-term targets forecasting 15%-20% annual sales growth and solid EBITDA gains.

Antero Resources is my largest, highest-conviction trade, driven by bullish long-term fundamentals for natural gas and favorable industry positioning. AR stands out for its ultra-low-cost reserves, superior pricing, strong balance sheet, and significant exposure to LNG exports and AI/data center demand. I rate AR a Strong Buy, expecting potential upside of 40% to 200%+ if natural gas prices normalize and industry trends play out as anticipated.

Winnipeg, Manitoba--(Newsfile Corp. - October 21, 2025) - Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) ("Snow Lake"), a uranium exploration and development company, announces a major strategic expansion with the creation of Kadmos Energy Services LLC ("Kadmos"), a new U.S. based nuclear energy company dedicated to the design and deployment of small modular reactors ("SMRs"), with an initial focus on light water reactors.

PHILADELPHIA and VANCOUVER, British Columbia, Oct. 21, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce a collaboration with Memorial Sloan Kettering Cancer Center's (MSK's) Therapeutics Accelerator Cohort program to accelerate the clinical development of Bria-OTS+, BriaCell's next generation personalized off-the-shelf immunotherapy, for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers.

GREENWICH, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Stardust Power Inc. (NASDAQ: SDST) ("Stardust Power" or the "Company"), an American developer of battery-grade lithium carbonate, announced today that it has executed a Letter of Intent (the “Agreement”) with Prairie Lithium for the supply of 6,000 metric tons per annum of lithium carbonate equivalent (“LCE”) in the form of lithium chloride (“LiCl”).

Subsidiary expected to pursue DoD and DHS contracts with focus on non-lethal BolaWrap® 150 devices, DFR-X drone interdiction technology, and CUAS programs to enhance mission safety and operational readiness Subsidiary expected to pursue DoD and DHS contracts with focus on non-lethal BolaWrap® 150 devices, DFR-X drone interdiction technology, and CUAS programs to enhance mission safety and operational readiness

Sales of $18.6 billion Net earnings of $1.6 billion, or $6.95 per share Cash from operations of $3.7 billion and free cash flow of $3.3 billion Returned $1.8 billion of cash to shareholders through dividends and share repurchases Increased share repurchase authority by $2 billion to a total authorization of $9 billion Increased quarterly dividend by 5% to $3.45 per share Record backlog of $179 billion Updates 2025 outlook BETHESDA, Md. , Oct. 21, 2025 /PRNewswire/ -- Lockheed Martin Corporation [NYSE: LMT] today reported third quarter 2025 sales of $18.6 billion, compared to $17.1 billion in the third quarter of …

Brazilian planemaker Embraer's firm order backlog stood at a record $31.3 billion at the end of the third quarter, up 38% from a year earlier, according to a securities filing.

MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx™ in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure, to be presented at a cardiology conference in November 2025.

Amazon Web Services, a key provider of cloud infrastructure, had a daylong outage. Apple shares rallied to all-time highs after a report showed iPhone 17 sales were off to a good start.

FLWS, ALCO and CAR have been added to the Zacks Rank #5 (Strong Sell) List on Oct. 21, 2025.

Vancouver, Canada, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the enrollment of the last patient for the first cohort of its Phase I/IIa clinical trial evaluating CMND-100, the Company's proprietary MEAI-based oral drug candidate for the treatment of Alcohol Use Disorder (AUD).

Launched on December 16, 1998, the Utilities Select Sector SPDR ETF (XLU) is a passively managed exchange traded fund designed to provide a broad exposure to the Utilities - Broad segment of the equity market.

The WisdomTree Emerging Markets SmallCap Dividend ETF (DGS) was launched on 10/30/2007, and is a smart beta exchange traded fund designed to offer broad exposure to the Broad Emerging Market ETFs category of the market.

A smart beta exchange traded fund, the First Trust Dow Jones Global Select Dividend ETF (FGD) debuted on 11/21/2007, and offers broad exposure to the Foreign Large Value ETF category of the market.

Launched on July 24, 2000, the iShares S&P Small-Cap 600 Growth ETF (IJT) is a passively managed exchange traded fund designed to provide a broad exposure to the Small Cap Growth segment of the US equity market.

Launched on January 26, 2004, the Vanguard Financials ETF (VFH) is a passively managed exchange traded fund designed to provide a broad exposure to the Financials - Broad segment of the equity market.

Designed to provide broad exposure to the Style Box - Mid Cap Blend category of the market, the First Trust Mid Cap Core AlphaDEX ETF (FNX) is a smart beta exchange traded fund launched on 05/08/2007.

Looking for broad exposure to the Healthcare - Medical Devices segment of the equity market? You should consider the iShares U.S. Medical Devices ETF (IHI), a passively managed exchange traded fund launched on May 1, 2006.

Looking for broad exposure to the Large Cap Value segment of the US equity market? You should consider the Schwab Fundamental U.S. Large Company ETF (FNDX), a passively managed exchange traded fund launched on August 13, 2013.